Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Showing results (311-320 of 504) with videos related to

Pageof 51
Sort By:
Hematological Oncology|October 3, 2012
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic cloneRoberto Marasca, Rossana Maffei, Silvia Martinelli, et al.
Annals of Clinical and Translational Neurology|June 27, 2025
Detecting rs-fMRI Networks in Disorders of Consciousness: Improving Clinical InterpretabilityJean Paul Medina Carrion, Mario Stanziano, Ludovico D'Incerti, et al.
Leukemia|May 16, 2024
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 updateJitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, et al.
Leukemia & Lymphoma|June 23, 2017
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomideRossana Maffei, Stefania Fiorcari, Silvia Martinelli, et al.
British Journal of Haematology|February 10, 2011
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usageMichele Dal-Bo, Ilaria Del Giudice, Riccardo Bomben, et al.
Haematologica|December 9, 2016
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of <i>SF3B1</i> gene refines prognosis in treatment-naïve chronic lymphocytic leukemiaChiara Cavallini, Carlo Visco, Santosh Putta, et al.
Neuropsychological Rehabilitation|March 11, 2017
Evidence of altered pressure pain thresholds in persons with disorders of consciousness as measured by the Nociception Coma Scale-Italian versionDavide Sattin, Caroline Schnakers, Marco Pagani, et al.
British Journal of Haematology|May 11, 2011
Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia riskDalemari Crowther-Swanepoel, Maria Chiara Di Bernardo, Krzysztof Jamroziak, et al.
Journal of Thrombosis and Thrombolysis|August 18, 2020
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxisChiara Kessler, Hans Stricker, Daniela Demundo, et al.
British Journal of Haematology|April 25, 2022
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamicsEleonora Calabretta, Anna Guidetti, Francesca Ricci, et al.
Pageof 51

Showing results (311-320 of 504) with videos related to

Sort By:
Pageof 51
Hematological Oncology|October 3, 2012
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic cloneRoberto Marasca, Rossana Maffei, Silvia Martinelli, et al.
Annals of Clinical and Translational Neurology|June 27, 2025
Detecting rs-fMRI Networks in Disorders of Consciousness: Improving Clinical InterpretabilityJean Paul Medina Carrion, Mario Stanziano, Ludovico D'Incerti, et al.
Leukemia|May 16, 2024
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 updateJitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, et al.
Leukemia & Lymphoma|June 23, 2017
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomideRossana Maffei, Stefania Fiorcari, Silvia Martinelli, et al.
British Journal of Haematology|February 10, 2011
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usageMichele Dal-Bo, Ilaria Del Giudice, Riccardo Bomben, et al.
Haematologica|December 9, 2016
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of <i>SF3B1</i> gene refines prognosis in treatment-naïve chronic lymphocytic leukemiaChiara Cavallini, Carlo Visco, Santosh Putta, et al.
Neuropsychological Rehabilitation|March 11, 2017
Evidence of altered pressure pain thresholds in persons with disorders of consciousness as measured by the Nociception Coma Scale-Italian versionDavide Sattin, Caroline Schnakers, Marco Pagani, et al.
British Journal of Haematology|May 11, 2011
Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia riskDalemari Crowther-Swanepoel, Maria Chiara Di Bernardo, Krzysztof Jamroziak, et al.
Journal of Thrombosis and Thrombolysis|August 18, 2020
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxisChiara Kessler, Hans Stricker, Daniela Demundo, et al.
British Journal of Haematology|April 25, 2022
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamicsEleonora Calabretta, Anna Guidetti, Francesca Ricci, et al.
Pageof 51